We compared the levels of cell-free
human placental lactogen (hPL)
messenger RNA (
mRNA) in maternal plasma at 28 to 32 weeks of gestation between women with diagnosis of
placenta previa or invasive placenta and women with an uneventful pregnancy. Sensitivity and specificity of hPL
mRNA for the prediction of invasive placenta were further explored. Plasma hPL
mRNA were quantified by real-time
reverse-transcriptase polymerase chain reaction in women with
placenta previa (n = 13), invasive placenta (n = 5), and normal pregnancies (n = 92). Median (range) hPL
mRNA was significantly higher in women with
placenta previa, 782 (10-2301) copies/mL of plasma, and in those with invasive placenta, 615 (522-2102) copies/mL of plasma, when compared to normal pregnancies, 90 (4-4407) copies/mL of plasma, P < .01 and P < .05, respectively. We found a sensitivity of 100% and a specificity of 61.5% for the prediction of invasive placenta among women with
placenta previa. In conclusion, expression of hPL
mRNA is increased in plasma of women with
placenta previa and invasive placenta at 28 to 32 weeks of gestation.